News

AddToAny

Google+ Facebook Twitter Twitter

Infecting lab mice with SARS-CoV-2

A major hurdle to developing and testing new anti-viral therapies and vaccines for COVID-19 is the lack of good, widely available animal models of the disease. But an international team of researchers has developed a simple tool that they hope will help resolve this issue.

They created a gene therapy approach that can convert any lab mouse into one that can be infected with SARS-CoV-2 and develops COVID-like lung disease.

The gene therapy vector has now been made freely available to any researchers who want to use it.

Lead researcher Paul McCray said: “There is a pressing need to understand this disease and to develop preventions and treatments.

“We wanted to make it as easy as possible for other researchers to have access to this technology, which allows any lab to be able to immediately start working in this area by using this trick.”  

bit.ly/2VyUVT5

Picture Credit | iStock

Related Articles

Loss of smell

Through analysing new data collected through an app, Professor Sebastien Ourselin and colleagues have gained new insights into COVID-19 symptoms. 

Neutralising antibodies against SARS-CoV-2

A trio of papers describe newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV.

COVID-19 anti-viral therapy

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

COVID-19: a report from Melbourne, Australia

Medical Scientist Eileen Kelly reports on the impact of COVID-19 in Melbourne and the way the pandemic has been dealt with.

Top